FDA lifts approvals hold on Pliva facilities (Pharmaceutical Business Review)
The FDA has approved two generic drugs made by Croatian generic drugmaker Pliva and given tentative approval to a third. The FDA decision signifies that the agency is satisfied with the measures the company has taken to correct problems at its manufacturing facilities in Zagreb.

Kensey Nash Receives FDA 510(k) Clearance for TriActiv FX(R) Embolic Protection System (PR Newswire via Yahoo! Finance)
Kensey Nash Corporation today announced that it has received 510 clearance for its next generation TriActiv FX Embolic Protection System from the U.S. Food and Drug Administration .